How Firms Are Using ICH Q12 Guideline To Reduce US FDA Oversight Of Manufacturing Changes
Executive Summary
Sandoz reduced established conditions by 19% in one BLA; others are having similar successes in focusing change control oversight more narrowly. But there have been some pitfalls.